Translational Genomics and the Empowered Patient:The Linchpin of Cancer Success
Bridging Science and Patients: A Revolution in Cancer Treatment to unlock the power of translational genomics to empower cancer patients.
Bridging Science and Patients: A Revolution in Cancer Treatment to unlock the power of translational genomics to empower cancer patients.
Embracing a Metabolic Perspective: A New Era of Patient-Centered, Innovative Cancer Care, Transforming Treatment, and Empowering Individuals. Steve Holmes "Survival became an Unexpected [...]
Exploring the possibilities beyond a cholangiocarcinoma diagnosis, embracing critical thinking, collaboration, increasing patient empowerment
Unleashing your Power, One Question at a Time: Be Open, Be Willing, Be Consistent, and take control of your cancer challenge
Boehringer Ingelheim is studying BI 907828, an investigational MDM2-p53 antagonist, for advanced biliary tract or pancreatic cancer.
Discover the power of genomic understanding in curing your cancer. Learn about cells, genes, and genomics and your power within Steve Holmes "Improving [...]